|
IL106992A
(en)
|
1988-02-11 |
1994-06-24 |
Bristol Myers Squibb Co |
Acylhydrazone derivatives of anthracycline and methods for their preparation
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5977316A
(en)
|
1995-01-17 |
1999-11-02 |
The Board Of Trustees Of The University Of Kentucky |
Monoclonal antibody 1A7 and related polypeptides
|
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US7303749B1
(en)
|
1999-10-01 |
2007-12-04 |
Immunogen Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
AU6461201A
(en)
|
2000-07-12 |
2002-01-21 |
Idec Pharma Corp |
Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
KR20080087184A
(ko)
|
2001-01-31 |
2008-09-30 |
바이오겐 아이덱 인크. |
종양질환 치료를 위한 ｃｄ23 길항제의 용도
|
|
US20030103971A1
(en)
|
2001-11-09 |
2003-06-05 |
Kandasamy Hariharan |
Immunoregulatory antibodies and uses thereof
|
|
CN100574803C
(zh)
|
2001-01-31 |
2009-12-30 |
拜奥根Idec公司 |
免疫调节抗体在治疗肿瘤性疾病中的用途
|
|
CA2450793A1
(en)
|
2001-06-20 |
2002-12-27 |
Prochon Biotech Ltd. |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
BR122015016384B8
(pt)
|
2001-11-08 |
2021-07-27 |
Beijing Wantai Biological Pharmacy Entpr Co Ltd |
polipeptídio recombinante ou isolado, molécula de ácido nucléico, kit de diagnóstico para detectar a infecção pelo vírus da hepatite e, composição de vacina, composição farmacêutica, vetor de expressão recombinante, célula hospedeira transformada e uso do polipeptídeo recombinante ou isolado
|
|
MXPA04004634A
(es)
|
2001-11-16 |
2004-08-12 |
Idec Pharma Corp |
Expresion policistronica de anticuerpos.
|
|
EP1560596A1
(en)
|
2002-11-15 |
2005-08-10 |
Immunomedics, Inc. |
Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics
|
|
CA2508831C
(en)
|
2002-12-13 |
2012-05-01 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
US7534427B2
(en)
|
2002-12-31 |
2009-05-19 |
Immunomedics, Inc. |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
|
|
CN1802388B
(zh)
|
2003-05-09 |
2011-01-05 |
杜克大学 |
Cd20特异抗体及使用它们的方法
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
US7754209B2
(en)
|
2003-07-26 |
2010-07-13 |
Trubion Pharmaceuticals |
Binding constructs and methods for use thereof
|
|
US7241598B2
(en)
*
|
2004-06-29 |
2007-07-10 |
The Chinese University Of Hong Kong |
Frame-shifting PCR for germline immunoglobulin genes retrieval and antibody engineering
|
|
CA2572289A1
(en)
|
2004-06-30 |
2006-08-17 |
Centocor, Inc. |
Anti-mcp-1 antibodies, compositions, methods and uses
|
|
EP1838736B1
(en)
|
2005-01-05 |
2013-03-06 |
Biogen Idec MA Inc. |
Cripto binding molecules
|
|
CN101155831B
(zh)
|
2005-02-10 |
2015-08-19 |
贝勒研究院 |
抗干扰素α单克隆抗体及其使用方法
|
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
|
US20090041783A1
(en)
|
2005-04-28 |
2009-02-12 |
Mochida Pharmaceutical Co., Ltd. |
Anti-platelet membrane glycoprotein vi monoclonal antibody
|
|
ZA200709956B
(en)
|
2005-05-20 |
2009-02-25 |
Genentech Inc |
Pretreatment of a biological sample from an autoimmune disease subject
|
|
JP2008546647A
(ja)
|
2005-06-08 |
2008-12-25 |
デューク ユニバーシティ |
移植のための抗−ｃｄ１９抗体治療
|
|
US20080279850A1
(en)
|
2005-07-25 |
2008-11-13 |
Trubion Pharmaceuticals, Inc. |
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
|
|
RU2423381C2
(ru)
*
|
2005-07-25 |
2011-07-10 |
Трабьон Фармасьютикалз, Инк. |
Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
|
|
EP1806365A1
(en)
|
2006-01-05 |
2007-07-11 |
Boehringer Ingelheim International GmbH |
Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
|
|
EP2032606B1
(en)
|
2006-05-30 |
2013-11-27 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
NZ573646A
(en)
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
|
CN101563365B
(zh)
|
2006-08-03 |
2012-10-31 |
瓦西尼斯公司 |
抗-il-6单克隆抗体及其用途
|
|
JP2010507394A
(ja)
|
2006-10-24 |
2010-03-11 |
トルービオン ファーマスーティカルズ インコーポレイテッド |
改良免疫糖タンパク質のための物質および方法
|
|
US7846434B2
(en)
|
2006-10-24 |
2010-12-07 |
Trubion Pharmaceuticals, Inc. |
Materials and methods for improved immunoglycoproteins
|
|
RS53008B2
(sr)
|
2007-04-03 |
2022-12-30 |
Amgen Res Munich Gmbh |
Interspecijski specifičan cd3-epsilon vezujući domen
|
|
JP2010532764A
(ja)
|
2007-07-06 |
2010-10-14 |
トゥルビオン・ファーマシューティカルズ・インコーポレーテッド |
Ｃ末端に配置された特異的結合性ドメインを有する結合性ペプチド
|
|
PE20140196A1
(es)
|
2007-08-09 |
2014-03-19 |
Boehringer Ingelheim Int |
Anticuerpos anti-cd37
|
|
GB2454915B
(en)
|
2007-11-23 |
2012-02-15 |
Schlumberger Holdings |
Spooling apparatus for well intervention system
|
|
WO2009085576A2
(en)
|
2007-12-28 |
2009-07-09 |
Spring Bioscience Corporation |
Positive control cell pellets for immunohistochemistry and methods of use thereof
|
|
RU2531754C2
(ru)
|
2008-04-11 |
2014-10-27 |
ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ,ЭлЭлСи,US |
Связывающееся с cd37 иммунотерапевтическое средство и его комбинация с бифункциональным химиотерапевтическим средством
|
|
US7740844B2
(en)
|
2008-04-29 |
2010-06-22 |
Taiwan Liposome Co. Ltd |
Anti-VEGF monoclonal antibody
|
|
NZ610239A
(en)
|
2008-04-30 |
2014-11-28 |
Immunogen Inc |
Cross-linkers and their uses
|
|
CA2727278A1
(en)
|
2008-06-16 |
2010-01-21 |
Immunogen, Inc. |
Novel synergistic effects
|
|
AU2009270988A1
(en)
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
|
WO2010057047A1
(en)
|
2008-11-13 |
2010-05-20 |
Trubion Pharmaceutics, Inc. |
Cd37 immunotherapeutic combination therapies and uses thereof
|
|
CN102596922A
(zh)
|
2009-10-06 |
2012-07-18 |
免疫基因公司 |
有效的缀合物和亲水性连接体
|
|
CA2785907A1
(en)
|
2009-12-29 |
2011-07-28 |
Emergent Product Development Seattle, Llc |
Ron binding constructs and methods of use thereof
|
|
KR20130009760A
(ko)
|
2010-02-10 |
2013-01-23 |
이뮤노젠 아이엔씨 |
Ｃｄ２０ 항체 및 이의 용도
|
|
US9175086B2
(en)
|
2010-02-10 |
2015-11-03 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
SG10201501803YA
(en)
|
2010-03-12 |
2015-05-28 |
Immunogen Inc |
Cd37-binding molecules and immunoconjugates thereof
|
|
WO2011130580A1
(en)
|
2010-04-15 |
2011-10-20 |
Alper Biotech, Llc |
Monoclonal antibodies against her2 antigens, and uses therefor
|
|
ME03353B
(me)
*
|
2011-03-29 |
2019-10-20 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
AU2012236210B2
(en)
|
2011-04-01 |
2016-02-04 |
Immunogen, Inc. |
CD37-binding molecules and immunoconjugates thereof
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
CA2858964A1
(en)
|
2011-12-13 |
2013-06-20 |
Nordic Nanovector As |
Chimeric therapeutic anti-cd37 antibodie hh1
|
|
RU2014140119A
(ru)
*
|
2012-03-30 |
2016-05-27 |
Иммьюноджен, Инк. |
Способы повышения эффективности терапии на основе cd37
|
|
EP2849783A1
(en)
|
2012-05-16 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
Combination of cd37 antibodies with further agents
|
|
US20140120083A1
(en)
|
2012-11-01 |
2014-05-01 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
CN107753954A
(zh)
|
2012-12-13 |
2018-03-06 |
免疫医疗公司 |
功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量
|
|
WO2014143807A2
(en)
|
2013-03-15 |
2014-09-18 |
Stromatt Scott |
Anti-cd37 antibody and bcr pathway antagonist combination therapy for treatment of b-cell malignancies and disorders
|
|
CA2911962A1
(en)
|
2013-06-07 |
2014-12-11 |
Roy H. Larsen |
Method for upregulating antigen expression
|
|
IL312865B2
(en)
|
2013-09-11 |
2025-06-01 |
Eagle Biologics Inc |
Liquid protein formulations containing viscosity-lowering agents
|
|
JP6478989B2
(ja)
|
2013-11-07 |
2019-03-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
抗ｃｄ２０抗体とｂｔｋ阻害剤とを用いた併用療法
|
|
WO2015116729A2
(en)
|
2014-01-28 |
2015-08-06 |
Emergent Product Development Seattle, Llc |
Anti-cd37 antibody and anti-cd20 antibody combination therapy for treatment of b-cell malignancies and disorders
|
|
WO2015175533A2
(en)
|
2014-05-13 |
2015-11-19 |
Immunogen, Inc. |
Anti-cd37 immunoconjugate dosing regimens
|
|
EP3302561A4
(en)
|
2015-06-08 |
2019-02-06 |
Debiopharm International SA |
COMBINATIONS OF ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODIES
|
|
KR102766022B1
(ko)
|
2015-08-28 |
2025-02-10 |
데비오팜 인터네셔날 에스 에이 |
Cd37 의 검출을 위한 항체 및 검정
|
|
EP3535297B1
(en)
|
2016-11-02 |
2022-08-10 |
Debiopharm International, S.A. |
Methods for improving anti-cd37 immunoconjugate therapy
|
|
US12144818B2
(en)
|
2018-05-30 |
2024-11-19 |
Debiopharm International, S.A. |
Method for treating cancer in a human patient by administering an anti-CD37 immunoconjugate using various dosing regimens
|